Clinical Trial Update: Aripiprazole in Body Focused Repetitive Behaviors [Phase 2]

View source ↗

Summary

This update reports a Phase 2 trial of aripiprazole for body-focused repetitive behaviors (trichotillomania and excoriation disorder) that is not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excoriation Disorder
• Trichotillomania

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: University of Chicago | Conditions: Trichotillomania (Hair-Pulling Disorder), Dermatillomania | Phase 2 | Status: NOT_YET_RECRUITING